U.S., March 24 -- ClinicalTrials.gov registry received information related to the study (NCT07488637) titled 'Woundsome Revascularization in Chronic Limb-Threatening Ischemia' on March 18.
Brief Summary: Chronic limb-threatening ischemia (CLTI) is the most severe form of peripheral artery disease and remains a major health problem. Although the angiosome concept was introduced to guide revascularization by restoring direct blood flow to the affected tissue, its usefulness is limited by anatomical variations, collateral circulation, and wounds involving multiple territories. The emerging "woundsome" concept focuses instead on improving arterial perfusion directly to the wound area, recognizing that both direct revascularization and effectiv...